Tenax Therapeutics TENX
NASDAQ TENX
$1.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Tenax Therapeutics (TENX) Current Deferred Revenue (2012 - 2014)

Updated

Analysis

Tenax Therapeutics (TENX) Current Deferred Revenue (2012 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tenax Therapeutics 76.96 Mn -371.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2014 123,786.00
Jul 31, 2013 50,937.00
Apr 30, 2013 185,068.00
Apr 30, 2012 244,013.00
API Access

Tenax Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TENX&period=max&api_key=YOUR_API_KEY